CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXTUS2244411052

Current stock price

41.35 USD
-0.05 (-0.12%)
Last:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • In the past year CXT was profitable.
  • In the past year CXT had a positive cash flow from operations.
  • In the past 5 years CXT has always been profitable.
  • In the past 5 years CXT always reported a positive cash flow from operatings.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CXT's Return On Assets of 4.66% is fine compared to the rest of the industry. CXT outperforms 70.16% of its industry peers.
  • CXT has a Return On Equity of 11.58%. This is in the better half of the industry: CXT outperforms 75.00% of its industry peers.
  • With a decent Return On Invested Capital value of 7.93%, CXT is doing good in the industry, outperforming 75.81% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CXT is above the industry average of 8.20%.
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROIC 7.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • CXT has a Profit Margin of 8.76%. This is in the better half of the industry: CXT outperforms 79.84% of its industry peers.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • With an excellent Operating Margin value of 15.91%, CXT belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • CXT's Gross Margin of 42.48% is fine compared to the rest of the industry. CXT outperforms 72.58% of its industry peers.
  • CXT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. CXT Health Analysis

2.1 Basic Checks

  • CXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CXT has more shares outstanding than it did 1 year ago.
  • CXT has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CXT has an Altman-Z score of 1.85. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.85, CXT is not doing good in the industry: 65.32% of the companies in the same industry are doing better.
  • CXT has a debt to FCF ratio of 5.75. This is a neutral value as CXT would need 5.75 years to pay back of all of its debts.
  • The Debt to FCF ratio of CXT (5.75) is comparable to the rest of the industry.
  • CXT has a Debt/Equity ratio of 0.91. This is a neutral value indicating CXT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.91, CXT is doing worse than 85.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Altman-Z 1.85
ROIC/WACC0.84
WACC9.42%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that CXT should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.50, CXT is not doing good in the industry: 76.61% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.20 indicates that CXT should not have too much problems paying its short term obligations.
  • CXT's Quick ratio of 1.20 is on the low side compared to the rest of the industry. CXT is outperformed by 66.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.2
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. CXT Growth Analysis

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • The Earnings Per Share has been growing slightly by 1.12% on average over the past years.
  • The Revenue has grown by 11.43% in the past year. This is quite good.
  • Measured over the past years, CXT shows a decrease in Revenue. The Revenue has been decreasing by -9.71% on average per year.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.32% yearly.
  • Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 4.29% on average per year.
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.31%
Revenue Next 2Y5.29%
Revenue Next 3Y4.29%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.18 indicates a reasonable valuation of CXT.
  • Based on the Price/Earnings ratio, CXT is valued cheaper than 92.74% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.21, CXT is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.58, which indicates a very decent valuation of CXT.
  • Based on the Price/Forward Earnings ratio, CXT is valued cheaper than 91.13% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (23.13), we can say CXT is valued rather cheaply.
Industry RankSector Rank
PE 10.18
Fwd PE 9.58
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaply inside the industry as 89.52% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CXT is valued cheaply inside the industry as 90.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.98
EV/EBITDA 8.51
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)1.62
PEG (5Y)9.09
EPS Next 2Y8.32%
EPS Next 3YN/A

6

5. CXT Dividend Analysis

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.75%. Purely for dividend investing, there may be better candidates out there.
  • CXT's Dividend Yield is rather good when compared to the industry average which is at 0.47. CXT pays more dividend than 93.55% of the companies in the same industry.
  • CXT's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

  • The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
  • CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of CXT decreased recently.
Dividend Growth(5Y)6.42%
Div Incr Years1
Div Non Decr Years1
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 26.88% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • The dividend of CXT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.88%
EPS Next 2Y8.32%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (4/7/2026, 11:23:47 AM)

41.35

-0.05 (-0.12%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners113.86%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner Change5.59%
Market Cap2.38B
Revenue(TTM)1.66B
Net Income(TTM)145.10M
Analysts81.82
Price Target91.36 (120.94%)
Short Float %12.25%
Short Ratio7.87
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP26.88%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.06%
Min EPS beat(2)0.03%
Max EPS beat(2)0.1%
EPS beat(4)4
Avg EPS beat(4)1.37%
Min EPS beat(4)0.03%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)10
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)5.54%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)1.89%
Max Revenue beat(2)4.78%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.37%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.26%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 10.18
Fwd PE 9.58
P/S 1.43
P/FCF 11.98
P/OCF 9.83
P/B 1.9
P/tB N/A
EV/EBITDA 8.51
EPS(TTM)4.06
EY9.82%
EPS(NY)4.32
Fwd EY10.44%
FCF(TTM)3.45
FCFY8.35%
OCF(TTM)4.2
OCFY10.17%
SpS28.84
BVpS21.81
TBVpS-8.15
PEG (NY)1.62
PEG (5Y)9.09
Graham Number44.64
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROCE 10.34%
ROIC 7.93%
ROICexc 8.69%
ROICexgc 29.25%
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
FCFM 11.97%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
ROICexc(3y)13.26%
ROICexc(5y)12.51%
ROICexgc(3y)48.49%
ROICexgc(5y)45.78%
ROCE(3y)15.59%
ROCE(5y)14.95%
ROICexgc growth 3Y-18.71%
ROICexgc growth 5Y16.5%
ROICexc growth 3Y-13.43%
ROICexc growth 5Y8.62%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Debt/EBITDA 3.08
Cap/Depr 40.53%
Cap/Sales 2.61%
Interest Coverage 4.74
Cash Conversion 65.25%
Profit Quality 136.66%
Current Ratio 1.5
Quick Ratio 1.2
Altman-Z 1.85
F-Score4
WACC9.42%
ROIC/WACC0.84
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.31%
Revenue Next 2Y5.29%
Revenue Next 3Y4.29%
Revenue Next 5YN/A
EBIT growth 1Y-14.09%
EBIT growth 3Y0.45%
EBIT growth 5Y1.82%
EBIT Next Year18.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.55%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y12.8%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


How profitable is CRANE NXT CO (CXT) stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


What is the financial health of CRANE NXT CO (CXT) stock?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


What is the earnings growth outlook for CRANE NXT CO?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to grow by 6.3% in the next year.